Medasorb Technologies Corp
SEC CIK 1175151 · MSBT.OB · last insider filing 2026-06-16
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Chan Phillip P. | Director · President and CEO | filed 2008 - 2026 |
| Capponi Vincent | Director · See Remarks | filed 2006 - 2025 |
| Jones Edward Raymond | Director | filed 2007 - 2025 |
| Sobel Alan D. | Director | filed 2015 - 2025 |
| Bator Michael G. | Director | filed 2015 - 2025 |
| Kim Jiny | Director | filed 2022 - 2025 |
| Kraus Al | Director · President & CEO | filed 2006 - 2023 |
| Gunton James T. | Director | filed 2008 - 2015 |
| Rubin Joseph | Director | filed 2006 - 2014 |
| Miller William R | Director | filed 2007 - 2008 |
| Katz Kurt | Director | filed 2006 - 2008 |
| Whalen Martin F | Director | filed 2007 - 2008 |
| Bowes Joseph G | Director · President, Secretary, CEO, CFO | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Mariani Peter J | Chief Financial Officer | filed 2024 - 2026 |
| Deliargyris Efthymios | Chief Medical Officer | filed 2020 - 2025 |
| Bloch Kathleen P. | Interim CFO | filed 2013 - 2024 |
| D'Amico Alex | Chief Financial Officer | filed 2023 - 2023 |
| Mortensen Eric R. | Chief Medical Officer | filed 2017 - 2019 |
| Bartlett Robert Hawes | Chief Medical Officer | filed 2009 - 2017 |
| Berger Ronald | See Remarks | filed 2013 - 2013 |
| Bocchino Thomas | Chief Financial Officer | filed 2012 - 2012 |
| Lamadrid David | Chief Financial Officer | filed 2006 - 2011 |
| Winchester James F | Chief Medical Officer | filed 2006 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.